Marlon Byrd

Chicago Sun-Times eager to be Marlon Byrd’s judge, jury, executioner

25 Comments

OK, I’m dubious about Marlon Byrd’s claims that his positive test for a breast-cancer-treating, estrogen-blocking, steroid-masking drug had nothing to do with enhancing his performance. A couple of bigwigs at the Chicago Sun-Times are anything but, however. They’re positive Byrd is lying through his teeth:

Now, I’m sure De Luca, Deputy Managing Editor, News and Sports, and Morrissey, columnist, have done exhaustive research on the topic. That topic being how to kick people when they’re down. Byrd might be a career cheater, for all I know. Or he might well be as clean as anyone in the sport. One thing I’m pretty sure about: if he recently started cheating, he’s pretty terrible at it.

Oh, and there’s one more relevant fact: the drug found in Byrd’s system isn’t performance enhancing. But don’t let that stop the snark-fest guys.

Giants acquire Gordon Beckham from the Braves

MINNEAPOLIS, MN - JULY 27: Gordon Beckham #7 of the Atlanta Braves hits an RBI double against the Minnesota Twins during the first inning of the game on July 27, 2016 at Target Field in Minneapolis, Minnesota. (Photo by Hannah Foslien/Getty Images)
Hannah Foslien/Getty Images
Leave a comment

The Giants have acquired infielder Gordon Beckham from the Braves in exchange for cash considerations, David O’Brien of the Atlanta Journal-Constitution reports.

Eduardo Nunez injured his hamstring on Sunday, leaving the Giants with another hole to fill at third base. Beckham isn’t eligible for inclusion on the Giants’ postseason roster.

Beckham, 30, hit .217/.300/.354 with five home runs and 30 RBI in 273 plate appearances with the Braves. He spent most of his time at second base but also spent some time at third base and shortstop. Beckham has nearly 1,500 career innings at third base, so moving back to the hot corner shouldn’t be a big deal.

Steven Matz to undergo “imminent” elbow surgery

NEW YORK, NY - AUGUST 14:  Steven Matz #32 of the New York Mets pitches in the first inning against the San Diego Padres at Citi Field on August 14, 2016 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Jim McIsaac/Getty Images
2 Comments

Mets GM Sandy Alderson addressed the media about the status of starter Steven Matz on Tuesday afternoon. Alderson said that Matz will undergo “imminent” elbow surgery to address a bone spur in the lefty’s elbow, Marc Carig of Newsday reports. That will end Matz’s season.

Matz was expected to return this past Friday, but was scratched due to shoulder soreness. According to Carig, the shoulder doesn’t appear to be a major issue.

Matz, 25, finishes the season with a 9-8 record, a 3.40 ERA, and a 129/31 K/BB ratio in 132 1/3 innings. It was a pretty good showing for his first full season in the majors.

The Mets enter Tuesday’s action a half-game up on the Giants for the first of two National League Wild Card slots. If the Mets can secure one of those slots and then advance to the NLDS, they will likely use a rotation that includes Noah Syndergaard, Bartolo Colon, Seth Lugo, and Robert Gsellman.